Cocker 发表于 2025-3-23 11:22:24

Submitted on: 20 July 2019.
Revised on: 18 September 2019.
Accepted on: 16 October 2019.

___________________CARDIOVASCULAR DRUGS AND THERAPY

招惹 发表于 2025-3-23 15:00:40

Submitted on: 27 February 2017.
Revised on: 30 March 2017.
Accepted on: 18 April 2017.

___________________CARDIOVASCULAR DRUGS AND THERAPY

先驱 发表于 2025-3-23 21:20:38

http://reply.papertrans.cn/1/48/4775/4775-13.png

Palatial 发表于 2025-3-24 01:16:14

http://reply.papertrans.cn/1/48/4775/4775-14.png

领导权 发表于 2025-3-24 05:05:55

http://reply.papertrans.cn/1/48/4775/4775-15.png

MILL 发表于 2025-3-24 09:10:42

Submitted on: 23 November 2007.
Revised on: 28 December 2007.
Accepted on: 17 February 2008.

___________________CARDIOVASCULAR DRUGS AND THERAPY

青石板 发表于 2025-3-24 12:45:34

http://reply.papertrans.cn/1/48/4775/4775-17.png

Breach 发表于 2025-3-24 15:04:04

Submitted on: 03 April 1999.
Revised on: 01 June 1999.
Accepted on: 20 June 1999.

___________________CARDIOVASCULAR DRUGS AND THERAPY

暴露他抗议 发表于 2025-3-24 21:29:13

Submitted on: 27 February 2013.
Revised on: 27 June 2013.
Accepted on: 21 July 2013.

___________________CARDIOVASCULAR DRUGS AND THERAPY

印第安人 发表于 2025-3-25 01:36:08

http://reply.papertrans.cn/1/48/4775/4775-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊CARDIOVASCULAR DRUGS AND THERAPY 2024/2025影响因子:3.146 (CARDIOVASC DRUG THER) (0920-3206). (PHARMACOLOGY & PHARMACY